BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36383412)

  • 1. The
    Gupta N; Song H; Wu W; Ponce RK; Lin YK; Kim JW; Small EJ; Feng FY; Huang FW; Okimoto RA
    Elife; 2022 Nov; 11():. PubMed ID: 36383412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.
    Bose R; Karthaus WR; Armenia J; Abida W; Iaquinta PJ; Zhang Z; Wongvipat J; Wasmuth EV; Shah N; Sullivan PS; Doran MG; Wang P; Patruno A; Zhao Y; ; Zheng D; Schultz N; Sawyers CL
    Nature; 2017 Jun; 546(7660):671-675. PubMed ID: 28614298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
    Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of
    Singh R; Cohen ASA; Poulton C; Hjortshøj TD; Akahira-Azuma M; Mendiratta G; Khan WA; Azmanov DN; Woodward KJ; Kirchhoff M; Shi L; Edelmann L; Baynam G; Scott SA; Jabs EW
    Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
    Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ
    EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.
    Barros-Silva JD; Paulo P; Bakken AC; Cerveira N; Løvf M; Henrique R; Jerónimo C; Lothe RA; Skotheim RI; Teixeira MR
    Neoplasia; 2013 Jul; 15(7):720-6. PubMed ID: 23814484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.
    Kawamura-Saito M; Yamazaki Y; Kaneko K; Kawaguchi N; Kanda H; Mukai H; Gotoh T; Motoi T; Fukayama M; Aburatani H; Takizawa T; Nakamura T
    Hum Mol Genet; 2006 Jul; 15(13):2125-37. PubMed ID: 16717057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
    Linn DE; Bronson RT; Li Z
    PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
    Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C
    Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model.
    Rahim S; Minas T; Hong SH; Justvig S; Çelik H; Kont YS; Han J; Kallarakal AT; Kong Y; Rudek MA; Brown ML; Kallakury B; Toretsky JA; Üren A
    PLoS One; 2014; 9(12):e114260. PubMed ID: 25479232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
    Shin S; Oh S; An S; Janknecht R
    Oncol Rep; 2013 Jan; 29(1):306-14. PubMed ID: 23076342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
    Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
    Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.
    Oh S; Shin S; Lightfoot SA; Janknecht R
    Cancer Res; 2013 Aug; 73(16):5110-9. PubMed ID: 23774214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
    Shin S; Kim TD; Jin F; van Deursen JM; Dehm SM; Tindall DJ; Grande JP; Munz JM; Vasmatzis G; Janknecht R
    Cancer Res; 2009 Oct; 69(20):8102-10. PubMed ID: 19789348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERF: genomic organization, chromosomal localization and promoter analysis of the human and mouse genes.
    Liu D; Pavlopoulos E; Modi W; Moschonas N; Mavrothalassitis G
    Oncogene; 1997 Mar; 14(12):1445-51. PubMed ID: 9136988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function
    Huang FW; Mosquera JM; Garofalo A; Oh C; Baco M; Amin-Mansour A; Rabasha B; Bahl S; Mullane SA; Robinson BD; Aldubayan S; Khani F; Karir B; Kim E; Chimene-Weiss J; Hofree M; Romanel A; Osborne JR; Kim JW; Azabdaftari G; Woloszynska-Read A; Sfanos K; De Marzo AM; Demichelis F; Gabriel S; Van Allen EM; Mesirov J; Tamayo P; Rubin MA; Powell IJ; Garraway LA
    Cancer Discov; 2017 Sep; 7(9):973-983. PubMed ID: 28515055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer.
    Mehra R; Tomlins SA; Shen R; Nadeem O; Wang L; Wei JT; Pienta KJ; Ghosh D; Rubin MA; Chinnaiyan AM; Shah RB
    Mod Pathol; 2007 May; 20(5):538-44. PubMed ID: 17334343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion.
    Rahim S; Beauchamp EM; Kong Y; Brown ML; Toretsky JA; Üren A
    PLoS One; 2011 Apr; 6(4):e19343. PubMed ID: 21559405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
    Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
    Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
    Tomlins SA; Rhodes DR; Perner S; Dhanasekaran SM; Mehra R; Sun XW; Varambally S; Cao X; Tchinda J; Kuefer R; Lee C; Montie JE; Shah RB; Pienta KJ; Rubin MA; Chinnaiyan AM
    Science; 2005 Oct; 310(5748):644-8. PubMed ID: 16254181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.